LFA-1 integrin antibodies inhibit leukocyte α4β1-mediated adhesion by intracellular signaling

Blood. 2016 Sep 1;128(9):1270-81. doi: 10.1182/blood-2016-03-705160. Epub 2016 Jul 21.

Abstract

Binding of intercellular adhesion molecule-1 to the β2-integrin leukocyte function associated antigen-1 (LFA-1) is known to induce cross-talk to the α4β1 integrin. Using different LFA-1 monoclonal antibodies, we have been able to study the requirement and mechanism of action for the cross-talk in considerable detail. LFA-1-activating antibodies and those inhibitory antibodies that signal to α4β1 induce phosphorylation of Thr-758 on the β2-chain, which is followed by binding of 14-3-3 proteins and signaling through the G protein exchange factor Tiam1. This results in dephosphorylation of Thr-788/789 on the β1-chain of α4β1 and loss of binding to its ligand vascular cell adhesion molecule-1. The results show that with LFA-1 antibodies, we can activate LFA-1 and inhibit α4β1, inhibit both LFA-1 and α4β1, inhibit LFA-1 but not α4β1, or not affect LFA-1 or α4β1 These findings are important for the understanding of integrin regulation and for the interpretation of the effect of integrin antibodies and their use in clinical applications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies / immunology
  • Antibodies / pharmacology*
  • Cell Adhesion / drug effects
  • Cell Adhesion / immunology
  • Cell Line
  • Humans
  • Integrin alpha4beta1 / immunology*
  • Leukocytes / cytology
  • Leukocytes / immunology*
  • Lymphocyte Function-Associated Antigen-1 / immunology*
  • Phosphorylation / drug effects
  • Phosphorylation / immunology
  • Signal Transduction / drug effects*
  • Signal Transduction / immunology

Substances

  • Antibodies
  • Integrin alpha4beta1
  • Lymphocyte Function-Associated Antigen-1